Skip to main content

Table 2 Assessment of morphological remission and maintenance of complete remission (CR)

From: Methyltransferase-like 3 gene (METTL3) expression and prognostic impact in acute myeloid leukemia patients

BM blasts count

No

%

Assessment of early response to chemotherapy

40

 

 Blasts% day 28

  ≤ 5%

16

40

  > 5%

23

57.5

  Died

1

2.5

Assessment of maintenance of CR

 Blasts% 2 m

  ≤ 5%

26/36

72.2

  > 5%

8/36

22.2

  Died

2/36

5.5

 Blasts% 4 m

  ≤ 5%

22/29

75.9

  > 5%

7/29

24.1

 Blasts% 6 m

  ≤ 5%

20/29

68.9

  > 5%

9/29

31.1